Congenital Erythropoietic Porphyria (CEP) Clinical Trials in Cleveland, Ohio

A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP